Podcast Summary

Podcast: Becker’s Healthcare Podcast
Episode: Advancing Real World Wound Care with Dr. Jaideep Banerjee of Smith+Nephew
Date: September 26, 2025
Host: Erica Spicer Mason
Guest: Dr. Jaideep Banerjee, Director of Global Clinical and Medical Affairs, Smith+Nephew

Episode Overview

This episode explores real-world approaches to wound care, delving into the latest clinical research, persistent challenges, and actionable strategies for improving patient outcomes while reducing costs. Dr. Jaideep Banerjee, a leader in medical affairs and research at Smith+Nephew, shares insights from nearly two decades in wound care, highlights findings from a major real-world study, and offers clear takeaways for healthcare leaders navigating the complex landscape of chronic wound management.

Key Discussion Points & Insights

1. Dr. Banerjee’s Expertise and Background

[00:50–02:53]

• PhD in molecular, cell and developmental biology from Ohio State, with research focused on genetic signaling, oxygen deprivation in chronic wounds, and biofilms.
• Postdoctoral fellowships at U.S. Army Institute of Surgical Research and George Washington University, consulting experience with Walter Reed and others.
• Joined Smith+Nephew via Osiris Therapeutics, now Director of Medical Affairs.
• Passion for both research and clinical application, serving as peer reviewer and journal editor.

"Wound healing or wound care is not just one product... me and my team, we help advance wound care education and the scientific understanding behind our technologies."
— Dr. Banerjee [01:57]

2. Wound Care: The Current Landscape & Major Challenges

[03:39–06:03]

• Chronic wounds described as a “silent epidemic” in the U.S. and globally.
• Nearly 1 in 6 Medicare patients is affected, costing $22–23B annually.
• Major issues:
  • Wound recurrence due to incomplete healing.
  • Lack of standardization in wound care protocols and practices across facilities.
  • Necessity for better provider and patient education.

"The wound, even when you think it has closed, it will recur, it will open back up due to incomplete...healing."
— Dr. Banerjee [04:04]

• Importance of evidence-based, patient-centered care to improve consistency and outcomes.

3. Real-World Evidence: Recent Study and its Inspiration

[06:27–09:35]

• Focus: Examining the impact of enzymatic debridement (with collagenase Santyl) on early wound healing outcomes in a real-world setting.
• Motivation: Preclinical findings suggested collagenase byproducts not only aid debridement but also:
  • Modulate inflammation.
  • Stimulate tissue repair.
  • Support extracellular matrix remodeling.
• Aim: Investigate immediate wound responses (first 2–4 weeks following application), linking lab findings to clinical outcomes.

"The motivation was these new scientific papers that have come out which suggest that there are additional cellular and molecular signaling happening in the wound bed."
— Dr. Banerjee [08:49]

4. Study Highlights & Clinical Implications

[09:54–13:33]

• Large cohort: ~16,000 patients, 30,000 wounds (variety of types and sizes).
• Consistent reduction in wound size, regardless of etiology or dimensions:
  • ~15–20% reduction at 2 weeks.
  • ~40% at 4 weeks.
• Early improvements during typical inpatient stays (2–3 weeks) suggest that starting enzymatic debridement early—prior to discharge—can significantly enhance outcomes, facilitating smoother transitions to outpatient care.

"There was a consistent reduction in wound size in these patients who have been treated with Santyl...starting therapy even during the inpatient stay...can help drive earlier progress and better outcomes post discharge."
— Dr. Banerjee [10:55]

• Improved early wound bed preparation may reduce reliance on more expensive advanced therapies later, such as skin substitutes or cellular/tissue-based products.

"If you have a good wound bed preparation, you might be again saving costs in the...later phase...by probably needing lesser number of skin substitute or lesser number of advanced modalities."
— Dr. Banerjee [12:47]

5. Key Takeaways for Healthcare Leaders

[13:56–16:55]

• Emphasis on the acronym “TIME” for wound care best practices:
  • T: Tissue management (debridement of necrotic tissue)
  • I: Inflammation/infection control
  • M: Moisture balance
  • E: Edge of wound (epithelial advancement)
• Analogized to prepping and priming a surface before painting—a solid foundation ensures successful, lasting outcomes.
• Investing in comprehensive debridement and wound bed preparation upfront, even at higher initial cost, results in improved healing, reduced recurrence, and lower long-term costs.

"It's all about not only just superficially closing on, but making sure your quality of healing is better."
— Dr. Banerjee [15:07]

• Education for both providers and patients is essential—adherence to protocols dramatically influences healing rates and recurrence.

"If you risk keeping a wound unhealed...the risk of not closing on fast enough can actually be even more costly at the end."
— Dr. Banerjee [16:21]

Notable Quotes & Memorable Moments

• "Chronic wounds are considered a silent epidemic in the United States..."
  — Dr. Banerjee [03:39]

• "A product that's been in the market for almost 50 years, we're still learning new things about this."
  — Dr. Banerjee [09:54]

• "It's almost like if you're trying to paint your house, you need to do your sanding first and then apply a primer before you want to apply your paint so that your paint sticks there. So this is the same concept here."
  — Dr. Banerjee [14:24]

Important Timestamps

| Timestamp | Topic / Quote | |---------------|------------------| | 00:50 | Dr. Banerjee’s background and entry into wound care research | | 03:39 | The prevalence and cost of chronic wounds | | 04:04 | Incomplete healing and wound recurrence | | 06:27 | Introduction of key study and scientific motivation | | 09:54 | Study population, results, and major outcomes | | 12:47 | Cost implications of improved wound bed preparation | | 13:56 | The 'TIME' model and core takeaway for leaders | | 14:24 | The “painting your house” analogy | | 16:21 | Upfront investment versus downstream cost savings |

Conclusion

This episode underscores the urgent need for standardized, evidence-based approaches to wound care—anchored in robust provider and patient education, early and optimal debridement, and a holistic view of the healing process. Dr. Banerjee’s research and analogies make a compelling case for proactive investment in wound care foundations to drive better patient outcomes and fiscal responsibility for healthcare systems.